Indian firms see red over fresh attempts to tweak IPR laws
This article was originally published in Scrip
Executive Summary
Indian pharmaceutical firms are protesting against what they claim are attempts by multinational companies to influence and tweak critical aspects of India's intellectual property rights (IPR) legislation.